Table 2.

Showing demographic parameters of the COVID-19 patients with DKA (and combined DKA/HHS).

Parameter	Value
Age (years) [Median (IQR)]	45.5 (36.2–57.7) [7,8,[10], [11], [12], [13], [14], [15], [16],[18], [19], [20], [21],23,24,28]a
	57.0 (48.0–64.0) [22] b
	59.0 (42.3–70.0) [9]
Sex (N = 102) c	Male (n = 64, 63%)
	Female (n = 38, 37%)
Ethnicityd (N = 84)	Black (n = 30, 36%) e
	Hispanic (n = 19, 23%)
	White (Caucasian) (n = 10, 12%)
	Asian (n = 6, 7%)
	Mixed (n = 4, 5%)
	Others (n = 8, 9%)
	Unknown (n = 7, 8%)
Type of diabetes f (N = 97)	Pre-existing T1DM (n = 12, 12%)
	Pre-existing T2DM (n = 74, 77%)
	Newly diagnosed (n = 10, 10%)
	Gestational DM (n = 1, 1%)
Use of SGLT2 inhibitors g	7
BMI (kg/m2) [Median (IQR)]	26.6 (23.7–32.3) [7,[11], [12], [13],16,28] h
	24.7 (21.3–28.5) [22] b
	27.1 (23.2–33.0) [9]

COVID-19: Novel coronavirus disease; DKA: Diabetic ketoacidosis; HHS: Hyperglycemic hyperosmolar syndrome; IQR: Interquartile range; SGLT2: Sodium-glucose transporter 2; BMI: Body mass index.

^aAge calculated from individual patient data available from 16 studies.

^bOnly data of patients with isolated DKA has been shown.

^cIndividual data on patient sex were available in 102 patients from 18 studies [[7], [8], [9], [10], [11], [12], [13], [14], [15], [16],[18], [19], [20], [21], [22], [23], [24],28].

^dIndividual data on patient ethnicity were available in 84 patients from 4 studies [9,10,22,28].

^ePatients with black ethnicity include African-American, Black African, African and Afro-Caribbean patients.

^fIndividual data on type of diabetes were available in 97 patients from 15 studies [7,[9], [10], [11], [12], [13], [14],16,[18], [19], [20],[22], [23], [24],28].

^gUse of SGLT2 inhibitors was reported in 7 patients from 5 studies [[9], [10], [11],13,22].

^hBMI calculated from individual patient data available from 6 studies.